Absolute quantification of myocardial blood flow (MBF) with 15 O-water cardiac positron emission tomography (PET)/ CT has recently demonstrated to hold promising diagnostic value for the detection of coronary artery disease (CAD). However, methodological differences in utilized analysis software packages (SP) could affect generated MBF values, potentially prohibiting widespread clinical applicability of obtained normal thresholds. The aim of this study was to compare two validated non-commercial SP, Carimas and Cardiac VUer, for the quantification of MBF using 15 O-water PET.
Introduction
Non-invasive myocardial perfusion imaging (MPI) is widely used for the diagnostic evaluation of patients with known or suspected coronary artery disease (CAD). Conventional qualitative imaging approaches are based on visual estimates of relative perfusion, which relies on the presence of a reference area with normal myocardial perfusion. This hampers its diagnostic accuracy in patients with multi-vessel disease and/or microvascular dysfunction.
1,2 Quantitative myocardial perfusion measurements may therefore increase diagnostic accuracy. 3 Cardiac positron emission tomography (PET) is the established technique to non-invasively quantify myocardial perfusion in vivo. 4 For this purpose, several tracers have been developed and validated. Of these flow tracers, 15 O-water is considered the gold standard as it is freely diffusible and metabolically inert and therefore, all observed changes in radioactivity concentrations are solely dependent on blood flow. Nonetheless, until recently 15 O-water was not utilized in clinical practice due to the need for onsite tracer production, elaborate post-processing procedures, and the fact that the low signal gradient between myocardium and blood yielded clinically uninterpretable images. In recent years, however, the exponential growth in PET/CT facilities worldwide has been paralleled by both hardware and software developments that now enable automated generation of myocardial perfusion images with routine quantification of myocardial blood flow (MBF). Two non-commercial clinical tools, Carimas and Cardiac VUer, developed by university hospitals, have clinically been well validated in a comparison with invasive measures, and implementation in clinical cardiology is now feasible. 5, 6 Studies that have evaluated these tools, however, have revealed some discrepancies in optimal cut-off values to detect obstructive CAD. 7, 8 These software
solutions are based on a single-compartment model as described by Iida et al.
9
, yet differences exist in definitions of arterial input function, delineation of the myocardial wall, and spillover corrections between blood and tissue compartments. Impact of these differences on obtained MBF values is unknown. Therefore, comparison between these recently developed quantitative myocardial perfusion tools is warranted before the widespread application of 15 O-water PET can be advocated in clinical cardiology.
The current study was therefore conducted to compare two clinically used software packages Carimas and Cardiac VUer.
Materials and methods

Patients population
Data were obtained retrospectively from two comparable cohorts of symptomatic patients (in terms of age and gender distribution), who were clinically evaluated for CAD and therefore referred for MBF measurements. The first cohort (VUmc) consisted of a total of 50 randomly selected patients (32 men, age range 39 -78 years, mean age 58 + 12 year; 18 women, age range 39 -78 year, mean age 59 + 11 year). These patients were scanned at the VU university medical centre. The second cohort (Turku) also consisted of 50 randomly selected patients (32 men, age range 52 -74 year, mean age 63 + 6 year; 18 women, age range 51 -74 year, mean age 64 + 7 year), who were examined at the Turku PET Centre. None of the patients had a documented history of CAD. All the patients had an intermediate risk of CAD based on the Diamond and Forrester criteria. 10 Electrocardiography did not show signs of a previous myocardial infarction, and echocardiography showed a normal left ventricular function without wall motion abnormalities in all patients. Data were in part selected from previously published cohorts. 6, 7, 8, 11 Written informed consent was obtained in patients who participated in a prospective validation study. 6, 8 In the remaining subjects, the institutional review board approved this retrospective study and the requirement to obtain informed consent was waived.
Image acquisition
Scans from VUmc were performed on a Gemini TF 64 PET-CT (Philips Healthcare, Best, The Netherlands) 12 at the VU university medical centre (Amsterdam, the Netherlands). A 5 mL bolus injection of 370 MBq 15 O-water, followed by 35 mL saline (total duration 23 s), was administered simultaneously with the start of a list-mode emission scan of 6 min in the 3D mode. A slow, respiration averaged low-dose CT scan (LD-CT, 55 mAs, 120 kV, acquiring 20 cm in 12 s compared with ,5 s for a regular LD-CT) was performed after each emission scan to correct for photon attenuation and scatter. The emission scan was reconstructed into 22 frames (1×10, 8×5, 4 × 10, 2 × 15, 3 × 20, 2 × 30, and 2 × 60 s), using the standard (non-time of flight) 3D-RAMLA reconstruction algorithm. Two 15 O-water scans were performed sequentially: one under adenosine-induced stress conditions followed by one under rest conditions after a 10 min delay to allow for decay of radioactivity. Intravenous adenosine infusion (140 mg kg 21 min
21
) was started 2 min prior to injection of 15 O-water and was terminated after the LD-CT, following the stress scan was performed, to ensure similar circumstances during the stress 15 O-water scan and its corresponding LD-CT.
Scans from Turku were performed using on a hybrid 64-row Discovery VCT PET/CT scanner (General Electrics, WI, USA) at the Turku PET Centre (Turku, Finland). 15 ). Adenosine was started 2 min before the scan start and continued throughout the dynamic frame acquisition. To correct, for photon attenuation and scatter, a single LD-CT (80 mAs, 120 kV) was performed.
Data analysis
Quantitative MBF were obtained using two previously published software packages: Carimas 6 and Cardiac VUer. 5 Although some differences in implementation exist, both packages extract the arterial input function directly from the dynamic PET data, use an one-tissue compartment model with a correction for perfusable tissue fraction (PTF) for the estimation of MBF, and define myocardial segments according to the 17 segment model of the American Heart Association. 13 An overview of the important similarities and differences between Carimas and Cardiac VUer is listed in Table 1 . A more detailed description of the exact MBF quantification procedure for these packages can be found in elsewhere. 5, 6 All data were analysed by a single observer without prior experience in either software package or who was blinded to the clinical results of all patients. This observer was not involved in any phase of the development of either software package. The observer received a demonstration from the developers of each package and was given a small number of data sets (not included in this study) to become familiar with the software. After this brief training period, the VUmc cohort was analysed first. Scans were analysed in a random order for both Carimas and Cardiac VUer separately, although for any patient, stress and rest data were analysed in the same analysis session. To avoid any biases introduced due to a learning curve, the packages were switched after every fifth analysis. After a 2-week intermission where the observer refrained from analyses, this process was repeated. After another 2-week intermission period, this analysis schedule was subsequently applied to the scans of the Turku cohort. In this manner, each scan from each institute was analysed twice by the single observer.
MBF was analysed for the entire LV and for each of the three coronary territories 13 (LAD, left anterior descending artery; RCA, right coronary artery; LCx, left circumflex). Reported MBF values were averaged over the two separately conducted analyses of each patient by the single observer. Coronary flow reserve (CFR) was defined as the ratio of stress and rest MBF and calculated for the entire LV and for each of the three coronary territories. An unpaired t-test was used to study differences in MBF between both patient cohorts. Reproducibility of each software package was assessed using intraclass correlation coefficients (ICC). Correlation and agreement between both software packages were assessed with Pearson's correlation coefficient and Bland-Altman analysis whereas a paired t-test was used to test for significant differences between software packages. A P-value , 0.05 was considered statistically significant.
Results
Figure 1 (Carimas) and Figure 2 (Cardiac VUer) display examples of the user interfaces of the software packages. Both interfaces allow for a comprehensive reading of both qualitative and quantitative nature in the evaluation of perfusion for an individual patient. An overview of patient characteristics can be found in Table 2 .
Global analysis
The average MBF for both rest and stress obtained with each software package for the entire LV and each of the coronary territories separately is given in Figure 3 . , respectively, P ¼ 0.01). CFR was comparable between software packages (2.78 + 0.87 and 2.73 + 0.87, respectively, P ¼ 0.27). Mean differences between Carimas and Cardiac VUer are shown in Table 3 . Figure 4 shows the correlation between global MBF values. There was a high and significant correlation between MBF values obtained with either package (r ¼ 0.963, P , 0.001). Bland-Altman analysis displayed a mean difference of 20.06, which was not statistically different from zero (95% confidence interval 20.61 to 0.49 mL min 21 g
21
). Likewise, correlation for CFR was high (r ¼ 0.851, P , 0.001) Bland-Altman analysis displayed a mean difference of 20.06, which was not statistically different from zero (95% confidence interval 20.98 to 0.87).
Regional analysis
When analysis was conducted at a regional level, as illustrated in Figure 3 , rest MBF for the LAD territory as obtained with Carimas was slightly higher than Cardiac VUer, while for the other territories, Carimas produced slightly lower values, even though all differences were small (1.11 + 0.32 and 1.00 + 0. 22 ). An overview of the mean differences can be seen in Table 3 . MBF correlations were also significant for the three vascular territories ( Figure 5 ). CFR correlations per vascular territory were lower when compared with MBF (r ¼ 0.805, r ¼ 0.839, r ¼ 0.834 for LAD, RCA, and LCx, respectively, all P , 0.001). In addition, Bland-Altman analysis displayed a mean difference that was not significantly different from zero for all territories for both CFR and MBF.
Apical segment
As depicted in Figure 6 , the distal apical segment (no. 17) generally produces relative augmented flow values in relation to the rest of the myocardium. To circumvent this issue, Carimas incorporates an additional analysis for the LAD region excluding the distal apical segment (LADwa). The agreement between packages for the LAD territory slightly improved by omission of this segment ( Figure 7 , r ¼ 0.954 for LADwa and r ¼ 0.942 for LAD), and the slope of the linear fit was no longer significantly different from unity (P ¼ 0.51 
Software reproducibility
Intra-observer ICCs are shown in Table 4 . Software reproducibility was excellent for both software packages (as indicated by ICCs .0.90).
Comparison of MBF between patient cohorts
There was no significant difference in average global MBF during rest and stress for patients scanned in either institute for both software packages (P . 0.50 for all). Regional analysis revealed no significant differences in resting or hyperaemic MBF for the RCA and LCx vascular territories between software packages and institutes (P . 0.25 for all). For rest MBF of the LAD territory, a significant difference was found between patients from Vumc and Turku when data were analysed using Carimas (MBF of 1.16 + 0.33 and 1.03 + 0.31 mL min 21 g
21
, respectively, P ¼ 0.04). This difference was not observed when data were analysed using Cardiac Vuer (MBF of 1.00 + 0.25 and 0.98 + 0.20 mL min 21 g
, respectively, P ¼ 0.81), nor when the distal apical segment was omitted (MBF of 1.01 + 0.25 and 0.93 + 0.27 mL min 21 g
, respectively, P ¼ 0.13). For hyperaemic MBF, no significant differences were documented for the LAD territory between institutes for both software packages (P ¼ 0.84 for Carimas, P ¼ 0.72 for Cardiac Vuer).
Discussion
The use of absolute, quantitative MBF in clinical practice has gained interest to enhance the diagnostic accuracy for CAD.
1,2 For quantitative MBF to become a reliable clinical tool, values should be similar, independent of the type of scanner, analysis software, or tracer used, such that standardized cut-off values can be defined to distinguish between normal and ischaemic myocardium. The present study was conducted to evaluate the reproducibility of quantitative MBF analysis when using different non-commercial validated SP, Carimas 6 and Cardiac Vuer, 5 using data acquired with 15 O-water at two centres with two types of PET/CT scanners. Although the underlying modelling procedures are similar, differences in implementations may exist in definition of the arterial input function, spillover corrections, and automatic definition of myocardial segments ( Table 1 ). All of these factors could, to some extent, influence the generated flow values. However, despite these differences in implementations, an excellent agreement within and between SP was documented in this study. Intra-observer reproducibility was found to be excellent for global and regional MBF for each SP with ICC values of 0.90 and higher. It should be emphasized that a novice operator, with basic cardiac anatomy knowledge, analysed the scans after just a brief training period. This training level proved to be sufficient to ensure high reproducibility of results. Previous studies pertaining these SP have likewise documented that interobserver variability is equally low. 6, 14 These findings have important clinical implications, as they demonstrate that personnel with brief training can fulfil the task to generate reliable perfusion images upon which clinical decision-making is based. Moreover, post-processing time is in the order of minutes per scan and workload for staff is therefore low, which facilitates high patient throughput and allows rapid grading of (quantitative) MBF images.
Global MBF was comparable between SP and excellent agreement in regional values obtained with either package was observed. However, despite this excellent agreement, minute discrepancies were observed at a regional level of some vascular territories.
Nonetheless, these differences reached statistical significance due to the large sample size and paired analysis of the data. In addition, some minor differences in exact definition of the myocardial segments may introduce small differences in obtained MBF values. This is especially pronounced for the most distal apex as the largest differences were found for the LAD territory. For hyperaemia, only the LAD territory displayed slightly higher flow values with Carimas, which also resulted in augmented global values. For both rest and hyperaemic MBF in the LAD territory, this difference was abolished when LAD without the most distal apex was considered in the Carimas SP. For CFR, only the RCA territory yielded some higher values using Carimas.
These observed slight disparities in (stress) MBF and CFR, however, are not likely to be of any clinical impact as reported ischaemic threshold values of PET studies using various tracers (i.e.
82
Rubidium, 13 documented inter-software (and observer) variability can thus be considered negligible in relation to such clinical variability to diagnose significant CAD. Similar to the aforementioned agreement of average MBF data, correlations for MBF at a global and regional scale were excellent and characterized by r-values of 0.94 and higher. Furthermore, slopes of the fits were close to unity and intercepts close to zero, indicating that results obtained with either package are interchangeable. It should be noted that for the LAD territory, slope of the correlation was significantly different from unity (0.89) as flow values increasingly diverged at higher flow rates between SP. This observation could be ascribed to augmented perfusion of the most distal apical segment. The latter is not likely to represent a physiological phenomenon but is related to the fact that this small anatomical segment is susceptible to artefacts due to high spillover fractions from adjacent tissue and blood pool and due to patient and cardiac motion. Accordingly, when this segment was disregarded when using the Carimas SP, differences were no longer apparent and slope of the correlation approached unity (0.99), which was in line with results for other vascular territories. Correlations for CFR were generally governed by slightly more scatter as compared with absolute MBF. This pattern is not unanticipated as the combination of two measurements as a ratio by default introduces larger margins of error. As a consequence, CFR should be considered less reliable in terms of reproducibility between packages when compared with MBF alone. As recent studies have revealed that hyperaemic MBF is of comparable or even superior diagnostic accuracy than CFR, these results further support the use of absolute flow quantification to evaluated CAD and may facilitate stress only by protocols. 15 O-water, irrespective of the scanner or scanning protocol used.
The current study was conducted using in-house developed software from two academic centres with considerable experience in cardiac perfusion imaging using 15 O-water PET. This was in part instigated by a paucity of commercial available software, as until recently the use of this perfusion tracer was considered unsuitable for clinical use given the low signal gradient between the blood and the myocardium. Recent advances in software and hardware, however, now enable to produce high quality (quantitative) images using 15 O-water as demonstrated by the investigated SP. Although these noncommercial packages are available at no costs, they are not embedded in professional software systems with accompanying commercial support. Quantification software for alternative MBF tracers such as Rubidium, recent data demonstrate that different SP also display high agreement. 24, 25 Studies are ongoing to evaluate the validity of commercial packages to routinely quantify MBF using 15 O-water and 82 Rubidium PET. Although the software and scanner type for 15 O-water PET may be interchangeable, the use of different tracers is not. 15 O-water is the only freely diffusible tracer with complete myocardial extraction regardless of flow rate. Extraction of 13 N-ammonia and even more so for 82 Rubidium levels off at increasing flow rates, which influences quantification of MBF. As a consequence, normal values and ischaemic thresholds for these tracers are generally reported to be lower when compared with 15 O-water. For diagnostic purposes, more prospectively studies are therefore warranted for each tracer individually to establish reliable ischaemic cut-off values.
Of final note, assessment of potential mismatch between the emission and transmission images due to patient motion was not routinely evaluated. As perfusion is estimated from the clearance rate of 15 O-water, it is virtually unaffected by potential attenuation artefacts.
In fact, it has recently been highlighted that attenuation correction can be omitted altogether for 15 O-water MBF studies and patient motion between emission and transmission data has no appreciable influence on estimated MBF. 26, 27 This is in contrast to tracers that employ MBF estimation from the accumulation rate of the tracer. 28 A limitation of this study is that not all patients were referred for invasive angiography and fraction flow reserve (FFR) measurements, which is considered the gold standard for the evaluation of CAD. Therefore, a direct comparison of results of both SP with those obtained using angiography and FFR could not be conducted in the current study. Further studies with respect to clinical performance of each SP and potential differences in optimal cut-off values to detect obstructive CAD are warranted.
Conclusion
For global and regional MBF, Carimas and Cardiac Vuer showed excellent agreement and intra-observer reproducibility. These results confirm that, for patients with intermediate likelihood of CAD, these validated SP are interchangeable and can be utilized for routine clinical practice of 15 O-water cardiac PET.
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